We are live on
!
Find out more
Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings
AUM
$39.1B
1-Year Est. Return
28.69%
This Fund
S&P 500
This Quarter
Est. Return
+9.12%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$21.6B
AUM Growth
+$1.94B
(+9.9%)
Cap. Flow
+$436M
Cap. Flow
% of AUM
2.02%
Top 10 Holdings %
Top 10 Hldgs %
28.47%
Holding
769
New
76
Increased
265
Reduced
236
Closed
94
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$130M |
| 2 |
UnitedHealth
UNH
|
+$111M |
| 3 |
Intuitive Surgical
ISRG
|
+$86.1M |
| 4 |
GE Aerospace
GE
|
+$76.1M |
| 5 |
Novartis
NVS
|
+$67.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$238M |
| 2 |
Microsoft
MSFT
|
+$83.2M |
| 3 |
Meta Platforms (Facebook)
META
|
+$71.8M |
| 4 |
LTHM
Livent Corporation
LTHM
|
+$66.7M |
| 5 |
Canadian Solar
CSIQ
|
+$52.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.12% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 9.5% |
| 4 | Consumer Discretionary | 8.67% |
| 5 | Communication Services | 8.16% |
Similar funds
HF
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q2 2023 Portfolio in Review
As of Q2 2023, Grantham, Mayo, Van Otterloo & Co (GMO) held 769 positions worth $21.6B, up 9.9% from $19.7B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q2 2023 filing shows 76 new, 265 increased, 236 reduced and 94 closed positions. Its largest new stake was GE Aerospace: 940,083 shares worth $82.4M. The largest sale was Medtronic, an estimated $238M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q2 2023 buy was GE Aerospace: 940,083 shares worth $82.4M.
- Grantham, Mayo, Van Otterloo & Co (GMO) added most to Abbott in Q2 2023, an estimated $130M increase.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q2 2023 reduction was Medtronic, cutting an estimated $238M.
- Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Occidental Petroleum in Q2 2023, selling an estimated $37.1M.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 28% of its $21.6B portfolio in Q2 2023.
- Grantham, Mayo, Van Otterloo & Co (GMO) opened 76 new positions and closed 94 in Q2 2023.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value rose 9.9% quarter-over-quarter to $21.6B.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2023, filed 14 Aug 2023.